European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment.

Background: Glaucoma treatments are mostly presented in uni-dose or multi-dose format. A certain number of patients with visual acuity and dexterity problems may have problems in instilling eye drops.

Aim: To assess patient satisfaction and ease of use of a preservative-free glaucoma treatment (dorzolamide/timolol) in a new and innovative patented multi-dose delivery system.

[Dry eye disease – diagnosis and treatment].

Dry eye disease is a frequent reason for patients to seek help. In our experience, it is an underdiagnosed and undertreated condition.